Dosidal · Switzerland
Linagliptin NOBEL
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:70123 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 70123 atc: A10BH05 |
| Source authority | Swissmedic |
| Read date | 2026-11-15T01:25:13Z |
| authorisation status | first_authorisation: 2025-11-25 term: zugelassen valid_until: 2030-11-24 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: A10BH05 authorisation_number: 70123 form: TAB holder: NOBEL Pharma Schweiz AG holder_partner_nr: 1102452 it_number: 07.06.2. name: Linagliptin NOBEL state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d537ZbUxI4vlJ_K2HWlAQtmtOkyW6bTQ286oE_IBif2Ksx1bONFOHrjas-8Rsw5UrrlJUgpVtYlUuJ7Iz-5j75RXAThe signed record is on this page as issued. Keyring and how to check it: https://dosidal-registry.ai/.well-known/jwks.json |
The signed record (DOSE-10060, JSON)
{"as_of":null,"authority":{"id":"70123","name":"Swissmedic","register":"OGD Praeparate"},"fields":{"authorisation_status":{"asserted_by":"node","clock":{"class":"short","expires_at":"2026-11-22T01:25:13Z"},"effective_from":"2025-11-25","read_at":"2026-11-15T01:25:13Z","source":{"published":"2026-10-31","publisher":"Swissmedic (OGD)","url":"https://ogd.swissmedic.cloud/ogd-arzneimittel/Daten/OGD.zip"},"state":"current","value":{"first_authorisation":"2025-11-25","term":"zugelassen","valid_until":"2030-11-24"}},"identity":{"asserted_by":"node","clock":{"class":"long","expires_at":"2027-02-13T01:25:13Z"},"effective_from":"2025-11-25","read_at":"2026-11-15T01:25:13Z","source":{"published":"2026-10-31","publisher":"Swissmedic (OGD)","url":"https://ogd.swissmedic.cloud/ogd-arzneimittel/Daten/OGD.zip"},"state":"current","value":{"atc":"A10BH05","authorisation_number":"70123","form":"TAB","holder":"NOBEL Pharma Schweiz AG","holder_partner_nr":"1102452","it_number":"07.06.2.","name":"Linagliptin NOBEL"}}},"instance":"CH-DOSE-10060","instance_version":"0.1","market":"CH","node":{"door":"https://mcp.dosidal.ai","id":"ch.dose-10060.org"},"notice":"Artificial intelligence makes mistakes. Read the regulator.","produced_at":"2026-11-15T01:25:15Z","record_id":"ch:authorisation:70123","schema_version":"1.0","signature":{"alg":"ES256","canon":"JCS","kid":"dosidal-record-1.9dbf5d53","sig":"7ZbUxI4vlJ_K2HWlAQtmtOkyW6bTQ286oE_IBif2Ksx1bONFOHrjas-8Rsw5UrrlJUgpVtYlUuJ7Iz-5j75RXA"},"standard":"DOSE-10060","standard_version":"1.0","subject":{"anchor":null,"id":"ch:authorisation:70123","identifiers":[{"system":"swissmedic-authorisation","value":"70123"},{"system":"atc","value":"A10BH05"}],"level":"authorisation","relations":[{"id":"ch:presentation:70123-001","rel":"authorisation_of"},{"id":"ch:presentation:70123-002","rel":"authorisation_of"}]},"supersedes":null,"version":1}